RE:RE:RE:RE:RE:RE:RE:RE:Exciting update!!All good points, Sailboat. And I agree that Philip appears to be the wrong guy to lead through commercialization, although the confidentiality agreements don't help us investors in gauging managements effectiveness either. Bringing Frank Holler with his corporate experience into operations by changing his role from Chairman to Executive Chair may help but this was done only recently on December 2. Likely too short a time yet to gauge his impact, if any. As Philip makes organizational changes all around him and nothing helps, it does start to suggest that he is the problem. The only other problem it could be is the science but it seems to be moving ahead nicely. I would like to see them bring in a heavy hitter to a position such as VP Corporate and Business affairs first before changing Philip's role. Of course, they would then issue more DSUs, options etc., for him adding to the dilution. DSUs are a form of compensation. What total compensation, (salary, DSUs,options, etc.) is the norm in their industry that will allow for hiring the right level of talent? At what point does it go from fair to feathering their own pockets? The shares represented by this forum are not enough to effect company change. That leaves us to vote with our feet by either hanging in here or moving on.